Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers

Issey Takehara; Takashi Yoshikado; Keiko Ishigame; Daiki Mori; Ken-Ichi Furihata; Nobuaki Watanabe; Osamu Ando; Kazuya Maeda; Hiroyuki Kusuhara; Yuichi Sugiyama

doi:10.1007/s11095-019-2585-8

Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers

Pharm Res. 2019 Feb 21;36(4):55. doi: 10.1007/s11095-019-2585-8.

Authors

Issey Takehara^{1

2}, Takashi Yoshikado^{3

4}, Keiko Ishigame⁴, Daiki Mori², Ken-Ichi Furihata⁵, Nobuaki Watanabe⁶, Osamu Ando⁶, Kazuya Maeda², Hiroyuki Kusuhara⁷, Yuichi Sugiyama²

Affiliations

¹ Biomarker Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
² Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
³ Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy, 601 Matano-cho, Totsuka-ku, Yokohama-shi, Kanagawa, 245-0066, Japan.
⁴ Sugiyama Laboratory, RIKEN Innovation Center, RIKEN, Yokohama, Japan.
⁵ P-One Clinic, Keikokai Medical Corp, Tokyo, Japan.
⁶ Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
⁷ Sugiyama Laboratory, RIKEN Innovation Center, RIKEN, Yokohama, Japan. kusuhara@mol.f.u-tokyo.ac.jp.

PMID: 30790061
DOI: 10.1007/s11095-019-2585-8

Abstract

There was a miscalculation of coproporphyrin I AUC_0-24h in the published article (Volume 35, Number 7). After the correction of AUC_0-24h, AUC ratio and R-square were re-calculated. Then, following corrections were made in the abstract, the body, Fig. 3, Fig. 4 and Table 2 in this article.

Publication types

Published Erratum